• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲人群中超过 7500 个 BRCA 变异揭示了 BRCA 变异的种族特异性、进化起源和有害性。

Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.

机构信息

Ministry of Education Frontiers Science Center for Precision Oncology, Cancer Centre and Institute of Translational Medicine, Department of Public Health and Medical Administration, Faculty of Health Sciences, University of Macau, Macao SAR, China.

出版信息

Int J Cancer. 2023 Mar 15;152(6):1159-1173. doi: 10.1002/ijc.34359. Epub 2022 Nov 30.

DOI:10.1002/ijc.34359
PMID:36385461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10098510/
Abstract

Pathogenic variation in BRCA1 and BRCA2 (BRCA) causes high risk of breast and ovarian cancer, and BRCA variation data are important markers for BRCA-related clinical cancer applications. However, comprehensive BRCA variation data are lacking from the Asian population despite its large population size, heterogenous genetic background and diversified living environment across the Asia continent. We performed a systematic study on BRCA variation in Asian population including extensive data mining, standardization, annotation and characterization. We identified 7587 BRCA variants from 685 592 Asian individuals in 40 Asia countries and regions, including 1762 clinically actionable pathogenic variants and 4915 functionally unknown variants (https://genemutation.fhs.um.edu.mo/Asian-BRCA/). We observed the highly ethnic-specific nature of Asian BRCA variants between Asian and non-Asian populations and within Asian populations, highlighting that the current European descendant population-based BRCA data is inadequate to reflect BRCA variation in the Asian population. We also provided archeological evidence for the evolutionary origin and arising time of Asian BRCA variation. We further provided structural-based evidence for the deleterious variants enriched within the functionally unknown Asian BRCA variants. The data from our study provide a current view of BRCA variation in the Asian population and a rich resource to guide clinical applications of BRCA-related cancer for the Asian population.

摘要

BRCA1 和 BRCA2(BRCA)的致病变异导致乳腺癌和卵巢癌的风险增加,BRCA 变异数据是 BRCA 相关临床癌症应用的重要标志物。然而,尽管亚洲大陆人口众多、遗传背景多样且生活环境多样化,但亚洲人群的综合 BRCA 变异数据仍然缺乏。我们对亚洲人群中的 BRCA 变异进行了系统研究,包括广泛的数据挖掘、标准化、注释和特征描述。我们从 40 个亚洲国家和地区的 685592 名亚洲个体中鉴定出 7587 个 BRCA 变体,包括 1762 个临床上可采取的致病性变体和 4915 个功能未知的变体(https://genemutation.fhs.um.edu.mo/Asian-BRCA/)。我们观察到亚洲 BRCA 变体在亚洲和非亚洲人群之间以及亚洲人群内部具有高度的种族特异性,这表明当前基于欧洲后裔人群的 BRCA 数据不足以反映亚洲人群中的 BRCA 变异。我们还提供了亚洲 BRCA 变异的进化起源和出现时间的考古证据。我们还进一步提供了功能未知的亚洲 BRCA 变体中富含有害变异的结构基础证据。我们的研究数据提供了亚洲人群中 BRCA 变异的最新视图,并为指导亚洲人群中与 BRCA 相关的癌症的临床应用提供了丰富的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/5914e77c3a3a/IJC-152-1159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/7493a87daa6a/IJC-152-1159-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/2cc477112ea0/IJC-152-1159-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/f9481dc23269/IJC-152-1159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/876e117082e2/IJC-152-1159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/5914e77c3a3a/IJC-152-1159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/7493a87daa6a/IJC-152-1159-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/2cc477112ea0/IJC-152-1159-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/f9481dc23269/IJC-152-1159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/876e117082e2/IJC-152-1159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9085/10098510/5914e77c3a3a/IJC-152-1159-g002.jpg

相似文献

1
Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.亚洲人群中超过 7500 个 BRCA 变异揭示了 BRCA 变异的种族特异性、进化起源和有害性。
Int J Cancer. 2023 Mar 15;152(6):1159-1173. doi: 10.1002/ijc.34359. Epub 2022 Nov 30.
2
Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.BRCA1/2 种系变异在不同种族间具有高度特异性:超过 30000 例中国遗传性乳腺癌和卵巢癌患者的证据。
Int J Cancer. 2019 Aug 15;145(4):962-973. doi: 10.1002/ijc.32176. Epub 2019 Feb 13.
3
Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.以葡萄牙BRCA致病变异为模型,研究人类混合基因对人类健康的影响。
BMC Genomics. 2024 Apr 27;25(1):416. doi: 10.1186/s12864-024-10311-4.
4
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.中国大陆家族性乳腺癌和卵巢癌患者中BRCA种系变异的患病率及谱系
Oncotarget. 2016 Feb 23;7(8):9600-12. doi: 10.18632/oncotarget.7144.
5
Ethnic-specific variation within Asia population: evidence from over 78 000 cancer and 40 000 non-cancer cases of Indian, Chinese, Korean and Japanese populations.亚洲人群中的种族特异性变异:来自印度、中国、韩国和日本人群中超过 78000 例癌症和 40000 例非癌症病例的证据。
J Med Genet. 2021 Nov;58(11):752-759. doi: 10.1136/jmedgenet-2020-107299. Epub 2020 Sep 22.
6
BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.中国卵巢癌患者和健康对照者的未选择全国队列中的 BRCA 种系突变。
Gynecol Oncol. 2018 Oct;151(1):145-152. doi: 10.1016/j.ygyno.2018.07.024. Epub 2018 Aug 2.
7
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.亚洲胰腺腺癌患者胚系 BRCA 突变:评估遗传检测风险类别的前瞻性研究。
Invest New Drugs. 2018 Feb;36(1):163-169. doi: 10.1007/s10637-017-0497-1. Epub 2017 Aug 7.
8
Mutations in BRCA-related breast and ovarian cancer in the South African Indian population: A descriptive study.BRCA 相关的乳腺癌和卵巢癌在南非印度人群中的突变:一项描述性研究。
Cancer Genet. 2021 Nov;258-259:1-6. doi: 10.1016/j.cancergen.2021.06.002. Epub 2021 Jun 15.
9
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.在阿拉伯裔乳腺癌和卵巢癌患者中,BRCA1 和 BRCA2 种系突变的高发率。
Breast Cancer Res Treat. 2018 Apr;168(3):695-702. doi: 10.1007/s10549-017-4635-4. Epub 2018 Jan 2.
10
Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.BRCA1 和 BRCA2 种系变异在中国客家乳腺癌和卵巢癌患者中的分析。
BMC Cancer. 2022 Aug 2;22(1):842. doi: 10.1186/s12885-022-09943-0.

引用本文的文献

1
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study.对关于“根据BRCA1/2突变类型和位点,PARP抑制剂维持治疗对新诊断卵巢癌的获益:一项多中心真实世界研究”信件的回复
ESMO Open. 2025 Jun;10(6):105289. doi: 10.1016/j.esmoop.2025.105289. Epub 2025 May 29.
2
Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis.种系变异对日本女性乳腺癌和卵巢癌风险的影响:一项原始队列研究和荟萃分析。
EBioMedicine. 2025 Jun;116:105758. doi: 10.1016/j.ebiom.2025.105758. Epub 2025 May 21.
3

本文引用的文献

1
Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study.拉美裔和美国西班牙裔个体进行遗传性乳腺癌和卵巢癌检测的种系致病性变异体流行率:一项横断面研究。
JCO Glob Oncol. 2022 Jul;8:e2200104. doi: 10.1200/GO.22.00104.
2
Distinct landscapes of deleterious variants in DNA damage repair system in ethnic human populations.不同族群人群 DNA 损伤修复系统中有害变异的景观。
Life Sci Alliance. 2022 May 20;5(9). doi: 10.26508/lsa.202101319. Print 2022 Sep.
3
Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
Long-Term Survival in BRCA1 Mutant Advanced Ovarian Cancer: Unveiling the Impact of Olaparib.
BRCA1 突变晚期卵巢癌的长期生存:揭示奥拉帕利的影响
Diagnostics (Basel). 2024 Aug 29;14(17):1898. doi: 10.3390/diagnostics14171898.
4
A global perspective on the ethnic-specific variation and its implication in clinical application.关于种族特异性变异及其在临床应用中的意义的全球视角。
J Natl Cancer Cent. 2022 Dec 15;3(1):14-20. doi: 10.1016/j.jncc.2022.12.001. eCollection 2023 Mar.
5
Pathogenic variants in human DNA damage repair genes mostly arose after the latest human out-of-Africa migration.人类DNA损伤修复基因中的致病变异大多出现在最近一次人类走出非洲的迁徙之后。
Front Genet. 2024 Jun 14;15:1408952. doi: 10.3389/fgene.2024.1408952. eCollection 2024.
6
Classification of MLH1 Missense VUS Using Protein Structure-Based Deep Learning-Ramachandran Plot-Molecular Dynamics Simulations Method.基于蛋白质结构的深度学习-构象分布图-分子动力学模拟方法对 MLH1 错义 VUS 的分类。
Int J Mol Sci. 2024 Jan 10;25(2):850. doi: 10.3390/ijms25020850.
7
Emerging treatment approaches for triple-negative breast cancer.三阴性乳腺癌的新兴治疗方法。
Med Oncol. 2023 Dec 1;41(1):5. doi: 10.1007/s12032-023-02257-6.
8
Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity.哈萨克族妇女早期乳腺癌遗传易感性的研究。
Oncotarget. 2023 Oct 4;14:860-877. doi: 10.18632/oncotarget.28518.
BRCA1 和 BRCA2 致病性变异的癌症风险特征扩展。
JAMA Oncol. 2022 Jun 1;8(6):871-878. doi: 10.1001/jamaoncol.2022.0476.
4
Assessing the Variations in Breast/Ovarian Cancer Risk for Chinese Carriers.评估中国携带者患乳腺癌/卵巢癌风险的差异。
J Oncol. 2022 Mar 26;2022:9390539. doi: 10.1155/2022/9390539. eCollection 2022.
5
Human pathogenic variants were originated during recent human history.人类致病性变异体是在人类近代历史中产生的。
Life Sci Alliance. 2022 Feb 14;5(5). doi: 10.26508/lsa.202101263. Print 2022 May.
6
Comprehensive Identification of Deleterious Missense VUS Variants Based on Their Impact on TP53 Structural Stability.基于对 TP53 结构稳定性的影响综合鉴定有害错义 VUS 变异。
Int J Mol Sci. 2021 Oct 20;22(21):11345. doi: 10.3390/ijms222111345.
7
The UCSC Genome Browser database: 2022 update.UCSC 基因组浏览器数据库:2022 年更新。
Nucleic Acids Res. 2022 Jan 7;50(D1):D1115-D1122. doi: 10.1093/nar/gkab959.
8
Mutalyzer 2: next generation HGVS nomenclature checker.Mutalyzer 2:下一代 HGVS 命名法检查器。
Bioinformatics. 2021 Sep 29;37(18):2811-2817. doi: 10.1093/bioinformatics/btab051.
9
Combining Ramachandran plot and molecular dynamics simulation for structural-based variant classification: Using variants as model.结合拉马钱德兰图和分子动力学模拟进行基于结构的变异分类:以变异为模型
Comput Struct Biotechnol J. 2020 Dec 2;18:4033-4039. doi: 10.1016/j.csbj.2020.11.041. eCollection 2020.
10
dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs.dbNSFP v4:一个全面的人类非同义突变和剪接位点 SNVs 转录体特异性功能预测和注释数据库。
Genome Med. 2020 Dec 2;12(1):103. doi: 10.1186/s13073-020-00803-9.